The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
The centre has initiated next generation sequencing (NGS) as a tool for undertaking studies on genomic epidemiology of pathogens
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
Pregabalin Capsules have an estimated market size of US $244 million for twelve months ending Sep 2022 according to IQVIA
This FDC has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation
The project will generate and supply green energy to fulfill about 50% present consumption of the company
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
EZHARMIA is the fifth innovative oncology medicine to be launched in Japan by Daiichi Sankyo in the past three years
The investment will enable the company to enter European markets as well as enhance margins in current markets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
